Latest Conference Articles

AmerisourceBergen and Good Neighbor Pharmacy are working to support policies that will help advance the pharmacy profession.

Join Total Pharmacy® for an exclusive virtual event focused on actionable business solutions to drive measurable change for community pharmacy.

As part of our ThoughtSpot 2021 podcast series, guest host Dr. Lonie Haynes leads the conversation with diversity experts on how pharmacists can work to reduce health disparities.

“If you follow the shopper, you will see the future,” said Wendy Liebmann, CEO and chief shopper at WSL Strategic Retail, during a session at the 2021 NACDS Total Store Expo.

NACDS Total Store Expo 2021 proved to be a success, with speakers covering key issues related to the pandemic, vaccine rollout, the changing health care landscape, and opportunities for growth.

Check out some of the highlights from this year's virtual ThoughtSpot conference and trade show.

NACDS highlights tools designed to help you build relationships, discover the next industry trends, and get what you want out of this year’s Total Store Expo.

NACDS Total Store Expo kicks off August 23 and continues through August 25.

Mahaska Drug of Oskaloosa, IA announced as annual Pharmacy of the Year award winner

Kenrik Duru, MD, MSHS presented a model of future projections of Medi-Cal on Diabetes Prevention Programs through current performance measures and struggles identified.

AmerisourceBergen is celebrating Good Neighbor Pharmacy’s 2021 Pharmacy of the Year Award finalists.

Educating families to alleviate fear in pediatric populations regarding the flu vaccine will improve the vaccination rate and protect high-risk children. Due to the negative effects of the flu in children with diabetes, it is vital that at-risk youth be vaccinated.

Study results showed there was no significant correlation between blood glucose levels and mortality or the rate of stay in intensive care units of hospitals for sick patients with diabetes, pneumonia, and COVID-19.

Texas-based pharmacy is one of three nationwide up for the award.

Iowa-based pharmacy is one of three nationwide up for the award.

California-based pharmacy is one of three nationwide up for the award

At the virtual Scientific Sessions for the American Diabetes Association, Jennifer Sherr, MD, discussed the findings of a study of the Omnipod 5 automated insulin delivery system in very young children with type 1 diabetes.

An oral abstract presentation at the American Diabetes Association Virtual 81st Scientific Sessions highlighted a cardioprotective benefit of sodium-glucose co-transporter-2 inhibitors.

At the virtual Scientific Sessions for the American Diabetes Association, a study shows that metformin can improve adolescent type 1 diabetes.

A study presented at the American Diabetes Association Virtual 81st Scientific Sessions evaluated metformin prescribing for patients with type 2 diabetes and chronic kidney disease.

A study presented during a poster session at the American Diabetes Association Virtual 81st Scientific Sessions evaluated performance, safety, and satisfaction of an extended-wear insulin infusion set in patients with type 1 diabetes.

A study from the 2021 ASCO Annual Meeting examined the effect that oral anticancer agent initiation may have on adherence rates in patients with multiple myeloma and chronic conditions.

A study from the 2021 ASCO Annual Meeting assessed the prevalence of oncology drug shortages and how they hinder care for patients with cancer.

A poster presentation at the 2021 ASCO Annual Meeting discussed survival trends among patients with chronic lymphocytic leukemia.

A community oncology practice implemented a team-based approach to utilizing biosimilars.

Results of the phase 3 OlympiA study evaluating olaparib as adjuvant therapy in high-risk early-stage breast cancer therapy were presented at the 2021 ASCO Annual Meeting.

A study highlighted at the 2021 ASCO Annual Meeting explored whether patients who received an influenza vaccine were at increased risk for immune-related adverse events from single-agent immune checkpoint inhibitors.

Results of the phase 3 RATIONALE 203 study were presented at the 2021 ASCO Annual Meeting.